CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,500 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01272687
NCT01272687N/ACompleted

Epidemiological Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation

CENTOGENE GmbH Rostock·observational·Posted Jan 10, 2011·Updated Apr 9, 2021

In Brief

An observational study for Parkinson Disease and Idiopathic Parkinson Disease. Completed, enrolled 1,500 participants across 15 sites in 2 countries.

Detailed Summary

The genotype-phenotype correlation in patients with Parkinson's disease with specific mutations in the glucocerebrosidase gene (Gaucher gene) is known from own clinical experiences as well as from case reports in the literature. The epidemiological study will determine the frequency of heterozygous mutations in the glucocerebrosidase gene and correlate to the clinical onset and development by measuring and documenting severity of symptoms (e.g. cognitive deficits, L-dopa responsiveness, depression) in clinically well-characterized Parkinson's patients.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesGermany, Thailand
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 10, 2011
Enrollment StartJan 1, 2011
Primary CompletionJun 1, 2016
Study CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 15.5 years ago